A double-blind, double-dummy, randomized, placebo-controlled, 2-arm, 2X2 crossover study comparing the effects of montelukast, inhaled budesonide, and placebo on lower leg growth in children (prepubertal, tanner stage I) with mild asthma.

Trial Profile

A double-blind, double-dummy, randomized, placebo-controlled, 2-arm, 2X2 crossover study comparing the effects of montelukast, inhaled budesonide, and placebo on lower leg growth in children (prepubertal, tanner stage I) with mild asthma.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Budesonide; Montelukast
  • Indications Asthma
  • Focus Pharmacodynamics
  • Sponsors Merck & Co
  • Most Recent Events

    • 19 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top